Inaktiver Wert

Chelsea Therapeutics International Ltd. Aktie

Aktien

Schlusskurs Nasdaq Andere Börsenplätze
- ^USD	-

Chelsea Therapeutics Presents Efficacy and Safety Data for NORTHERA at International Congress of Parkinson's Disease and Movement Disorders	12.06.14
Chelsea Therapeutics : Newman Ferrara LLP : Announces Investigation of Chelsea Therapeutics International Ltd.	09.05.14
Chelsea Therapeutics : Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Chelsea Therapeutics International, Ltd. Stockholders	09.05.14
Wall Street finit sur une note mitigée, baisse du Nasdaq	08.05.14
Chelsea Therapeutics Joins NORD in Promoting Awareness for Rare Disease Day	28.02.14

Sektor

	% 1. Jan.	Kap.
VERTEX PHARMACEUTICALS INCORPORATED	-2,31 %	103 Mrd.
REGENERON PHARMACEUTICALS, INC.	+0,56 %	95,28 Mrd.
ARGENX SE	+1,69 %	22,15 Mrd.
BIONTECH SE	-17,37 %	21,02 Mrd.
GENMAB A/S	-9,30 %	18,15 Mrd.
WUXI APPTEC CO., LTD.	-41,01 %	16,73 Mrd.
BEIGENE, LTD.	-14,85 %	16,05 Mrd.
NEUROCRINE BIOSCIENCES, INC.	+3,21 %	13,68 Mrd.
SAREPTA THERAPEUTICS, INC.	+33,54 %	12,17 Mrd.